Cargando…
Childhood-onset severe hypereosinophilic asthma: efficacy of benralizumab
Severe hypereosinophilic asthma in children is extremely rare. This letter adds to the existing literature by providing long-term follow-up, and is the first report of the marked efficacy of benralizumab after failure of other biologic treatments. https://bit.ly/2G7Tc2k
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792776/ https://www.ncbi.nlm.nih.gov/pubmed/33447610 http://dx.doi.org/10.1183/23120541.00339-2020 |